Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Currie

Showing results (181-190 of 231) with videos related to

Pageof 24
Sort By:
Biochemical and Biophysical Research Communications|April 30, 1984
Atriopeptins: a family of potent biologically active peptides derived from mammalian atriaD M Geller, M G Currie, K Wakitani, et al.
Gastroenterology|February 25, 2020
IW-3718 Reduces Heartburn Severity in Patients With Refractory Gastroesophageal Reflux Disease in a Randomized TrialMichael F Vaezi, Ronnie Fass, Nimish Vakil, et al.
Cell and Tissue Research|June 21, 2005
Phenotypic and functional characterisation of follicle-associated epithelium of rectal lymphoid tissueA Mahajan, S Naylor, A D Mills, et al.
Diabetes|February 1, 1993
Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formationR G Tilton, K Chang, K S Hasan, et al.
Neurogastroenterology and Motility|August 27, 2009
Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral painH Eutamene, S Bradesi, M Larauche, et al.
Science (New York, N.Y.)|September 10, 1976
Earth rotation measured by lunar laser rangingA Stolz, P L Bender, J E Faller, et al.
American Journal of Physiology. Renal Physiology|September 1, 2020
Praliciguat inhibits progression of diabetic nephropathy in ZSF1 rats and suppresses inflammation and apoptosis in human renal proximal tubular cellsGuang Liu, Courtney M Shea, Juli E Jones, et al.
Expert Review of Gastroenterology & Hepatology|February 23, 2019
Safety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysisJudy W Nee, Jeffrey M Johnston, Elizabeth P Shea, et al.
Frontiers in Public Health|March 9, 2026
Supporting Canadian families of children with disabilities: unmet needs and service gapsK Pozniak, A Swain, M Rodrigues, et al.
Gastroenterology|September 15, 2007
Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndromeViola Andresen, Michael Camilleri, Irene A Busciglio, et al.
Pageof 24

Showing results (181-190 of 231) with videos related to

Sort By:
Pageof 24
Biochemical and Biophysical Research Communications|April 30, 1984
Atriopeptins: a family of potent biologically active peptides derived from mammalian atriaD M Geller, M G Currie, K Wakitani, et al.
Gastroenterology|February 25, 2020
IW-3718 Reduces Heartburn Severity in Patients With Refractory Gastroesophageal Reflux Disease in a Randomized TrialMichael F Vaezi, Ronnie Fass, Nimish Vakil, et al.
Cell and Tissue Research|June 21, 2005
Phenotypic and functional characterisation of follicle-associated epithelium of rectal lymphoid tissueA Mahajan, S Naylor, A D Mills, et al.
Diabetes|February 1, 1993
Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formationR G Tilton, K Chang, K S Hasan, et al.
Neurogastroenterology and Motility|August 27, 2009
Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral painH Eutamene, S Bradesi, M Larauche, et al.
Science (New York, N.Y.)|September 10, 1976
Earth rotation measured by lunar laser rangingA Stolz, P L Bender, J E Faller, et al.
American Journal of Physiology. Renal Physiology|September 1, 2020
Praliciguat inhibits progression of diabetic nephropathy in ZSF1 rats and suppresses inflammation and apoptosis in human renal proximal tubular cellsGuang Liu, Courtney M Shea, Juli E Jones, et al.
Expert Review of Gastroenterology & Hepatology|February 23, 2019
Safety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysisJudy W Nee, Jeffrey M Johnston, Elizabeth P Shea, et al.
Frontiers in Public Health|March 9, 2026
Supporting Canadian families of children with disabilities: unmet needs and service gapsK Pozniak, A Swain, M Rodrigues, et al.
Gastroenterology|September 15, 2007
Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndromeViola Andresen, Michael Camilleri, Irene A Busciglio, et al.
Pageof 24